Investors Show Faith In Faeth’s Cancer Metabolism Strategy As Data Read Out At ESMO

Further Funding Based On More Data, FDA Clarity

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.